Ragweed Observational Study
Completed
- Conditions
- Ragweed Allergy
- Registration Number
- NCT01398137
- Lead Sponsor
- Circassia Limited
- Brief Summary
This is an observational to evaluate Total Rhinoconjunctivitis Symptom Score and rescue medication usage (as measured by Rescue Medication Score as a Combined Score to inform the design of a phase III field study with ToleroMune Ragweed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean daily Combined Score during the site-specific ragweed pollen period Daily during ragweed season expected to last approximately 8 weeks Combined score is the Total Rhinoconjunctivitis Score(TRSS)/8 added to the Rescue Medication Score
- Secondary Outcome Measures
Name Time Method Mean Rescue Medication Score during the site-specific ragweed pollen period Through 2011 ragweed season expected to last approximately 8 weeks Mean Rescue Medication Score during the site-specific peak ragweed pollen period Through 2011 ragweed season expected to last approximately 8 weeks Mean Combined Score during the site-specific peak ragweed pollen period Through 2011 ragweed season expected to last approximately 8 weeks Mean TRSS during the site-specific ragweed pollen period Through 2011 ragweed season expected to last approximately 8 weeks Mean TRSS during the site-specific peak ragweed pollen period Through 2011 ragweed season expected to last approximately 8 weeks Mean component scores of the TRSS (nasal and non nasal) during the site specific ragweed pollen period Through 2011 ragweed season expected to last approximately 8 weeks Mean component scores of the TRSS (nasal and non nasal) during the site specific peak ragweed pollen period Through 2011 ragweed season expected to last approximately 8 weeks Mean Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score during the site specific peak ragweed pollen period in a subset of the study population Through 2011 ragweed season approximately 8 weeks Weeks of partly controlled or uncontrolled asthma Through 2011 ragweed season expected to last approximately 8 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of rhinoconjunctivitis in ragweed allergy patients as studied in NCT01398137?
How does ToleroMune Ragweed compare to standard-of-care antihistamines in managing seasonal allergy symptoms?
What biomarkers correlate with symptom severity and medication use in ragweed-induced rhinoconjunctivitis?
What adverse events are associated with allergen immunotherapy for rhinoconjunctivitis in observational studies?
What combination therapies are being explored alongside allergen immunotherapy for ragweed allergy treatment?
